The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma

Gynecologic Oncology

Volumn 123, Issue 3, 2011, Pages 548-552

  Tanner, Edward J ^a   Leitao Jr , Mario M ^a   Garg, Karuna ^a   Chi, Dennis S ^a   Sonoda, Yukio ^a   Gardner, Ginger J ^a   Barakat, Richard R ^a   Jewell, Elizabeth L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cytoreduction; Surgery; Uterine carcinosarcoma

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CARCINOSARCOMA; CHEMORADIOTHERAPY; CYTOREDUCTIVE SURGERY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; UTERUS CARCINOSARCOMA; UTERUS SARCOMA;

AGED; AGED, 80 AND OVER; CARCINOSARCOMA; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OVARIECTOMY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALPINGECTOMY;

EID: 81155123086     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.08.020     Document Type: Article

References (20)

1. J.Y. Park, D.Y. Kim, D.S. Suh, J.H. Kim, Y.M. Kim, and Y.T. Kim Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007 J Cancer Res Clin Oncol 134 12 2008 1277 1287
2. S.E. Ferguson, C. Tornos, A. Hummer, R.R. Barakat, and R.A. Soslow Prognostic features of surgical stage I uterine carcinosarcoma Am J Surg Pathol 31 11 2007 1653 1661 (Pubitemid 350287563)
3. K. Galaal, F.M. Kew, K.F. Tam, A. Lopes, M. Meirovitz, and R. Naik Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma Eur J Obstet Gynecol Reprod Biol 143 2 2009 88 92
4. E. Sartori, L. Bazzurini, A. Gadducci, F. Landoni, A. Lissoni, and T. Maggino Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study Gynecol Oncol 67 1 1997 70 75 (Pubitemid 27433331)
5. S.M. Ueda, D.S. Kapp, M.K. Cheung, J.Y. Shin, K. Osann, and A. Husain Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths Am J Obstet Gynecol 198 2 2008 218 [e1-6]
6. P. Pautier, C. Genestie, A. Rey, P. Morice, B. Roche, and C. Lhommé Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma Cancer 88 6 2000 1425 1431 (Pubitemid 30155181)
7. S.E. Brooks, M. Zhan, T. Cote, and C.R. Baquet Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol Oncol 93 1 2004 204 208 (Pubitemid 38429571)
8. J.D. Wright, J. Fiorelli, P.B. Schiff, W.M. Burke, A.L. Kansler, and C.J. Cohen Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time Cancer 115 6 2009 1276 1285
9. N. Bansal, T.J. Herzog, V.E. Seshan, P.B. Schiff, W.M. Burke, and C.J. Cohen Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior Obstet Gynecol 112 1 2008 64 70
10. P. Inthasorn, J. Carter, S. Valmadre, P. Beale, P. Russell, and C. Dalrymple Analysis of clinicopathologic factors in malignant mixed Mullerian tumors of the uterine corpus Int J Gynecol Cancer 12 4 2002 348 353 (Pubitemid 34839832)
11. S.N. Nielsen, K.C. Podratz, B.W. Scheithauer, and P.C. O'Brien Clinicopathologic analysis of uterine malignant mixed Müllerian tumors Gynecol Oncol 34 3 1989 372 378 (Pubitemid 19218581)
12. C.T. Griffiths Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma Natl Cancer Inst Monogr 42 1975 101 104
13. W.E. Winter III, G.L. Maxwell, C. Tian, J.W. Carlson, R.F. Ozols, and P.G. Rose Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study J Clin Oncol 25 24 2007 3621 3627 (Pubitemid 47372600)
14. L.M. Landrum, K.N. Moore, T.K. Myers, G.S. Lanneau Jr., D.S. McMeekin, and J.L. Walker Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis Gynecol Oncol 112 2 2009 337 341
15. M.B. Thomas, A. Mariani, W.A. Cliby, G.L. Keeney, K.C. Podratz, and S.C. Dowdy Role of cytoreduction in stage III and IV uterine papillary serous carcinoma Gynecol Oncol 107 2 2007 190 193 (Pubitemid 47575711)
16. D.S. Chi, E.L. Eisenhauer, J. Lang, J. Huh, L. Haddad, and N.R. Abu-Rustum What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 103 2 2006 559 564 (Pubitemid 44602167)
17. J.N. Barlin, I. Puri, and R.E. Bristow Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis Gynecol Oncol 118 1 2010 14 18
18. D.S. Chi, E.L. Eisenhauer, O. Zivanovic, Y. Sonoda, N.R. Abu-Rustum, and D.A. Levine Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm Gynecol Oncol 114 2009 26 31
19. A. Hoos, J.J. Lewis, and M.F. Brennan Soft tissue sarcoma: prognostic factors and multimodal treatment Chirurg 71 7 2000 787 794
20. E. Brown, M. Stewart, T. Rye, A. Al-Nafussi, A.R. Williams, and M. Bradburn Carcinosarcoma of the ovary: 19 years of prospective data from a single center Cancer 100 10 2004 2148 2153 (Pubitemid 38580333)